Drugmaker Novartis filed a lawsuit May 29 against the state of Maryland over a new law that forbids manufacturers from "taking certain direct or indirect actions to limit or restrict the acquisition or delivery of a 340B drug."

Timothy Jacisin, PharmD, a senior pharmacist at Cooperman Barnabas Medical Center in Livingston, N.J., has been selected to join a national taskforce commissioned by the group responsible for accrediting pharmacy residents. He will help expand standards that protect pharmacists who…

As experts predict sprawling shortages of physicians in the near future, community pharmacists are well-positioned to care for minor ailments, according to researchers at Pullman-based Washington State University. 

Sagent Pharmaceuticals issued a voluntary recall of two lots of a cancer drug because of a  "potential presence of particulate matter," the FDA said May 29. 

Amid a looming shortage of pharmacists, health system pharmacy leaders are increasing their investments in technology and leveling up roles, according to a survey of 324 pharmacy directors of general and children's hospitals. 

The FDA has approved Bkemv as the first interchangeable biosimilar to Soliris to treat certain rare diseases.

In a phase 2/3 trial investigating the efficacy of Keytruda with two chemotherapies, tumors shrank among 3 in 5 patients with pleural mesothelioma, Merck said May 29. 

New Haven, Conn.-based Yale School of Medicine and Atlanta-based Emory University researchers found a weak association between FDA drug proxies and disease outcomes — putting into question the effectiveness of using proxies in the approval process.

Johnson & Johnson plans to buy the global rights to an experimental eczema therapy for $1.25 billion in cash, the company said May 28. 

An FDA advisory committee voted 7-4 against Novo Nordisk's experimental weekly insulin shot after a study found elevated hypoglycemia risks and no additional benefits from the candidate.